Partnership
Reconnect-ID is working on a version that will allow the collection of clinical metrics for scientific validation and final development of a marketable version.
Reconnect-ID is not considered a “medical product” and does not require “CE marking,” which substantially shortens the time until it reaches the markets.
Once this phase is completed, the incorporation of AI, VR or other technologies will be addressed.
Do you want to be part of the Reconnect-ID community?
Subscribe to learn about the clinical version and help improve it
Leave us your details and we’ll keep you updated on our progress